Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Molecular Psychiatry|July 28, 2022
Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathologyYunseon Yang, Min-Jong Seok, Ye Eun Kim, et al.Stem Cells Translational Medicine|April 26, 2014
Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategiesHansoo Park, Dohoon Kim, Chun-Hyung Kim, et al.Journal of Neurochemistry|February 18, 2005
In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neuronsChang-Hwan Park, Yang-Ki Minn, Ji-Yeon Lee, et al.Stem Cells (Dayton, Ohio)|November 22, 2012
Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathwayKyung-Soon Park, Young Cha, Chun-Hyung Kim, et al.The Journal of Clinical Investigation|May 18, 2011
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson diseaseYong-Hee Rhee, Ji-Yun Ko, Mi-Yoon Chang, et al.Cell Death and Differentiation|September 24, 2021
LIN28A enhances regenerative capacity of human somatic tissue stem cells via metabolic and mitochondrial reprogrammingKelvin Pieknell, Yanuar Alan Sulistio, Noviana Wulansari, et al.The EMBO Journal|November 22, 2019
LIN28A loss of function is associated with Parkinson's disease pathogenesisMi-Yoon Chang, Boram Oh, Jang-Eun Choi, et al.Progress in Neurobiology|May 30, 2021
Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatmentSeung Won Kim, Hye-Ji Woo, Eun Hee Kim, et al.Pageof 5